2016
DOI: 10.4172/2168-9857.1000158
|View full text |Cite
|
Sign up to set email alerts
|

A Case of Urachal Carcinoma

Abstract: Urachal carcinoma is a rare, non-urothelial carcinoma that represents less than one percent of all bladder cancers. We present the case of a 58-year-old man who presented with the acute onset of painless hematuria. Cystoscopy revealed a bladder mass, and subsequent biopsy of a liver mass confirmed the diagnosis of metastatic urachal adenocarcinoma. The patient initially underwent a chemotherapeutic regimen of 5-fluorouracil, leucovorin, gemcitabine, and cisplatin (GEM-FLP) given every four weeks. Our case illu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…recently treated a case of metastatic urachal adenocarcinoma with a novel regimen (Gem-FLP: 5-FU, leucovorin, gemcitabine, and cisplatin) and showed regression in the size of liver lesions in the interval imaging post 4 cycles of chemotherapy. [ 6 ] However, the patient progressed within 2 months posttreatment completion.…”
Section: Discussionmentioning
confidence: 99%
“…recently treated a case of metastatic urachal adenocarcinoma with a novel regimen (Gem-FLP: 5-FU, leucovorin, gemcitabine, and cisplatin) and showed regression in the size of liver lesions in the interval imaging post 4 cycles of chemotherapy. [ 6 ] However, the patient progressed within 2 months posttreatment completion.…”
Section: Discussionmentioning
confidence: 99%